Keywords:
Antifungals; Aspergillosis; Children; Diagnostic imaging; Fusariosis; Invasive fungal disease; Mucormycosis; Scedosporiosis
Abstract:
Invasive mould infection (IMI) is a major cause of morbidity and mortality in immunocompromised children. Outcomes for paediatric patients with IMI remain poor, due in part to the limitations of available diagnostic tools and therapeutic agents.